Rezolute, Inc. — Director's Dealing 2014

Sep 10, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AntriaBio, Inc. (FMYY)
CIK: 0001509261
Period of Report: 2014-04-01

Reporting Person: DOCKERY CARL (See remarks)
Reporting Person: ALPHA ADVISORS, LLC (See remarks)
Reporting Person: Alpha Venture Capital Partners, L.P. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1057693.084	Indirect
Common Stock	95153.916	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$2.34	2017-03-31	Common Stock (1057693.084)		Indirect
Warrant to Purchase Common Stock	$2.34	2017-03-31	Common Stock (96153.916)		Indirect

Footnotes

F1: Between April 1, 2014 and the date of filing of this Form 3, the Common Shares underwent a 1-for-6 reverse stock split. All stockholdings identified in this Form 3 represent post-stock split numbers. As of April 1, 2014 and on the date of filing of this Form 3, AA and Dockery owned beneficially 1,153,847 Common Shares and warrants to purchase 1,153,847 Common Shares. Of such Common Shares AVCP directly owned 1,057,693.084 Common Shares and warrants to purchase 1,057,693.084 Common Shares and AVCF directly owned 96,153.916 Common Shares and warrants to purchase 96,153.916 Common Shares.